Bhardwaj Lab
@BhardwajLab
Followers
924
Following
1K
Media
111
Statuses
606
Laboratory of Dr. Nina Bhardwaj🔬 Immunology and Immunotherapy @TischCancer @SinaiImmunol. Posts by lab members
NYC
Joined April 2021
RT @TischCancer: Atezolizumab in combination with personalized neoantigen vaccine for urothelial cancer. via @uroto….
0
2
0
Excited for #CICON25 this September in Utrecht, Netherlands🇳🇱! A leading international meeting focused on advancing cancer immunotherapy. U.S. researchers are strongly encouraged to participate!.🗓 Abstracts due June 1.🔗
0
1
4
RT @CD_AACR: By Mansi Saxena, @DrTomMarron, Philip Friedlander, @iskander, @BhardwajLab and colleagues @TischCancer @UNC.
0
1
0
RT @CD_AACR: From the May issue: PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and….
0
2
0
RT @TischCancer: Nina Bhardwaj, MD, PhD, is pleased to serve as Co-Chair of #CICON25. Registration is open now. @B….
0
5
0
RT @IcahnMountSinai: Results from a phase 1 study led by Drs. Nina Bhardwaj and @MattGalsky show that their custom-made vaccine, in combin….
0
2
0
RT @JonAnker1: See our study in @NatureCancer evaluating personalized neoantigen vaccine + atezo in urothelial cancer. First report in the….
0
3
0
RT @MattGalsky: We tested the feasibility and immunogenicity of a personalized neoantigen vaccine + PD-L1 blockade in #bladdercancer includ….
0
32
0
Belated post: last month we said goodbye to @JennaNewmanPhD, who was a postdoctoral fellow in the lab for 5 years. Congratulations on your exciting new journey as a Senior Scientist at @AstraZeneca! You’ve been a fantastic member of our lab in so many ways & we miss you already!
0
0
9
RT @SharonneHoltz32: Grateful to the @GOG for the opportunity to present our research at fellows forum and honored to receive the best over….
0
3
0
RT @TischCancer: Personalized cancer vaccine proves promising in a phase 1 trial via @medical_xpress .@BhardwajLab….
0
3
0
Congratulations to several members of our Vaccine and Cell Therapy Laboratory, past and present, on the publication of our PGV neoantigen vaccine trial data in Cancer Discovery! 🥳.
PGV001, a multi-peptide personalized neoantigen vaccine platform: Phase I study in patients with solid and hematological malignancies in the adjuvant setting .@BhardwajLab Thomas Marron, MD, PhD @IcahnMountSinai
1
8
33
RT @IcahnMountSinai: Congratulations to Dr. Nina Bhardwaj on being named a Fellow of the @AACR Academy Class of 2025. @BhardwajLab.
0
2
0
Congratulations @NinaBhardwaj !.
đź‘Ź Congratulations to CRI Scientific Advisory Council Associate Director Dr. Bhardwaj @BhardwajLab @IcahnMountSinai and CRI SAC member Dr. Vonderheide @PennMedicine, who have been named Fellows of the @AACR Academy Class of 2025! Learn more: #AACRFellows
0
2
16
Updated lab photo! Today we celebrated postdoctoral fellow Kazuki Sone, whose last day in the lab is tomorrow, before he heads to Japan for a Chief Researcher position. Thank you Kazuki for being a fantastic scientist and labmate, and congratulations on your new role!
0
1
19
RT @labonnelab: Francis Collins resigned from NIH yesterday. He rightly pointed out that it's Human Genome Project revolutionized every asp….
0
504
0
RT @madamscientist: Pitt to pause PhD admissions, following Vanderbilt and USC, because of uncertainty of NIH funding to academic universit….
0
554
0
RT @sitcancer: SITC is deeply concerned by the announcement from NIH that will cut billions of dollars in indirect costs. We urge the NIH &….
0
22
0
RT @NobelPrize: "I've benefitted in my own lab from having a diverse lab of coworkers.". To mark International Day of Women and Girls in Sc….
0
147
0